Literature DB >> 25253571

Antiphosphatidylserine antibodies as diagnostic indicators of antiphospholipid syndrome.

H Khogeer1, A Alfattani1, M Al Kaff1, T Al Shehri2, O Khojah3, T Owaidah4.   

Abstract

BACKGROUND: Antiphospholipid syndrome (APS) is an autoimmune condition that is diagnosed by the presence of at least one of the clinical manifestations (thrombosis and/or pregnancy failure) and one of antiphospholipid antibodies (aPL) laboratory tests. The most relevant aPL are lupus anticoagulant (LA), anti-beta2 glycoprotein I (aβ2GPI) and anticardiolipin (aCL). The clinical significance of other antibodies like anti-phosphatidylserine antibodies (aPS) is still under investigation.
OBJECTIVES: The aim of the study was to assess the diagnostic value of aPS antibodies, and to compare their utility to that of other aPL antibodies.
METHODS: We conducted a prospective observational study consisting of 212 patients with suspected thrombosis, pregnancy failure, or unexplained, prolonged clotting time. Data on demography, clinical presentation and autoantibody levels were assessed. Descriptive analysis, accuracy analysis, sensitivity, specificity, predictive value and likelihood ratio were calculated for aPS in comparison to other aPL.
RESULTS: The diagnostic value of aPS versus other aPL antibodies revealed the high specificity of aPS (87%), with 70% of aPS-positive patients being confirmed APS. When the aPS test was used as a single test, it was effective for detection of confirmed APS cases (p < 0.01). Among 28 confirmed primary APS cases, 75% of patients were positive for aPS (p < 0.003). Moreover, by using aPS we detected three additional confirmed APS cases and another three probable cases.
CONCLUSION: Our findings reveal a significant association between aPS and APS, especially when used to diagnosis clinical cases with other negative aPL tests. There is an independent association between aPS and primary APS. In addition, these results demonstrated the advantages of using aPS as a diagnostic test for APS.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Antiphospholipid antibodies; phosphatidylserine; pregnancy failure; thrombosis

Mesh:

Substances:

Year:  2014        PMID: 25253571     DOI: 10.1177/0961203314552462

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  5 in total

1.  Right Atrial Thrombus Mimicking a Myxoma: Synergism of Hormonal Contraceptives and Antiphospholipid Antibodies.

Authors:  Zeba Hashmath; Abhishek Bose; Ramses Thabet; Ajay K Mishra; Mark Kranis
Journal:  Tex Heart Inst J       Date:  2022-07-01

2.  Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series.

Authors:  Jacqueline A Madison; Kelsey Gockman; Claire Hoy; Ajay Tambralli; Yu Zuo; Jason S Knight
Journal:  Pediatr Rheumatol Online J       Date:  2022-02-23       Impact factor: 3.054

Review 3.  Risk of Thrombosis, Pregnancy Morbidity or Death in Antiphospholipid Syndrome.

Authors:  Martin Killian; Thijs E van Mens
Journal:  Front Cardiovasc Med       Date:  2022-03-01

4.  Antiphosphatidylserine Antibody as a Cause of Multiple Dural Venous Sinus Thromboses and ST-Elevation Myocardial Infarction.

Authors:  Chelsea Kathleen Varner; Caillin Wyse Marquardt; Peter Vincent Pickens
Journal:  Am J Case Rep       Date:  2018-08-31

5.  Takayasu Arteritis With Antiphosphatidylserine/Prothrombin Antibody-Positive Antiphospholipid Syndrome: Case Report and Literature Review.

Authors:  Shoichi Fukui; Shogo Hirota; Naoki Iwamoto; Hiroki Karata; Atsushi Kawakami
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.